BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37584869)

  • 1. Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States: An Update.
    Kilani Y; Kamal SAF; Vikash F; Vikash S; Aldiabat M; Alsakarneh S; Aljabiri Y; Sohail H; Kumar V; Numan L; Al Khalloufi K
    Dig Dis Sci; 2023 Oct; 68(10):4050-4059. PubMed ID: 37584869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Disparities in Inhospital Outcomes for Hepatocellular Carcinoma in the United States.
    Rajbhandari R; Simon RE; Chung RT; Ananthakrishnan AN
    Mayo Clin Proc; 2016 Sep; 91(9):1173-82. PubMed ID: 27497857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
    Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
    J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry.
    Wong RJ; Devaki P; Nguyen L; Cheung R; Nguyen MH
    Liver Transpl; 2014 May; 20(5):528-35. PubMed ID: 24415542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007.
    Robbins AS; Cox DD; Johnson LB; Ward EM
    Cancer; 2011 Oct; 117(19):4531-9. PubMed ID: 21448933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial, ethnic, and socioeconomic disparities impact post-liver transplant survival in patients with hepatocellular carcinoma.
    Huang DC; Yu RL; Alqahtani S; Tamim H; Saberi B; Bonder A
    Ann Hepatol; 2023; 28(5):101127. PubMed ID: 37286167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma: Analysis of the National Inpatient Sample From 2007 to 2014.
    Bodek DD; Everwine MM; Lunsford KE; Okoronkwo N; Patel PA; Pyrsopoulos N
    J Clin Gastroenterol; 2023 Mar; 57(3):311-316. PubMed ID: 35180149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
    Jones PD; Diaz C; Wang D; Gonzalez-Diaz J; Martin P; Kobetz E
    Dig Dis Sci; 2018 Feb; 63(2):515-528. PubMed ID: 29275448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Improvements in Racial Disparity in the Treatment of Hepatocellular Carcinoma: How Times Have Changed.
    Moten AS; Fagenson AM; Pitt HA; Lau KN
    J Gastrointest Surg; 2021 Oct; 25(10):2535-2544. PubMed ID: 33547582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
    Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance.
    Gutin L; Yao F; Dodge JL; Grab J; Mehta N
    JAMA Netw Open; 2019 Aug; 2(8):e1910326. PubMed ID: 31469395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
    Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
    Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
    Rich N; Tanriover B; Singal AG; Marrero JA
    Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
    Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
    Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparities in clinical presentation, surgical procedures, and hospital outcomes among patients with hepatocellular carcinoma in the United States.
    Chikovsky L; Kutuk T; Rubens M; Balda AN; Appel H; Chuong MD; Kaiser A; Hall MD; Contreras J; Mehta MP; Kotecha R
    Cancer Epidemiol; 2023 Feb; 82():102317. PubMed ID: 36566577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival.
    Sloane D; Chen H; Howell C
    J Natl Med Assoc; 2006 Dec; 98(12):1934-9. PubMed ID: 17225837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation.
    Ahn J; Liu B; Bhuket T; Wong RJ
    Dig Dis Sci; 2017 Apr; 62(4):1051-1057. PubMed ID: 28168576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
    Kardashian A; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Aucejo F; Tevar AD; Humar A; Verna EC; Halazun KJ; Chapman WC; Vachharajani N; Hoteit M; Levine MH; Nguyen MH; Melcher ML; Langnas AN; Carney CA; Mobley C; Ghobrial M; Amundsen B; Markmann JF; Sudan DL; Jones CM; Berumen J; Hemming AW; Hong JC; Kim J; Zimmerman MA; Nydam TL; Rana A; Kueht ML; Fishbein TM; Markovic D; Busuttil RW; Agopian VG
    Hepatology; 2020 Dec; 72(6):2014-2028. PubMed ID: 32124453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.